Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
DNA Sequence : the Journal of DNA Sequencing and Mapping|November 8, 2001
Isolation and characterisation of the ylmE homologue of Thermus thermophilusS Spada, Y Gibert, J T Pembroke, et al.Materials Today. Bio|June 25, 2020
Porcine mesothelium matrix as a biomaterial for wound healing applicationsH Capella-Monsonís, M A Tilbury, J G Wall, et al.Occupational Medicine (Oxford, England)|April 1, 1996
Enamel erosion related to winemakingM M Ferguson, R J Dunbar, J A Smith, et al.Journal of Materials Science. Materials in Medicine|May 13, 2006
The antibacterial effects of zinc ion migration from zinc-based glass polyalkenoate cementsD Boyd, H Li, D A Tanner, et al.Biomedical Materials (Bristol, England)|June 20, 2017
Battling bacterial infection with hexamethylene diisocyanate cross-linked and Cefaclor-loaded collagen scaffoldsE K Tsekoura, A L Helling, J G Wall, et al.Investigational New Drugs|January 1, 1997
Phase II trial to topotecan in hepatocellular carcinoma: a Southwest Oncology Group studyJ G Wall, J K Benedetti, M A O'Rourke, et al.The American Journal of Medicine|November 1, 1989
Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B StudyJ G Wall, R B Weiss, L Norton, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2000
A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancerR L Schilsky, R Bukowski, H Burris, et al.Anti-Cancer Drugs|August 1, 1992
A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 daysJ G Wall, H A Burris, D D Von Hoff, et al.Journal of Biomedical Materials Research. Part A|November 15, 2015
Stainless steel surface functionalization for immobilization of antibody fragments for cardiovascular applicationsA Foerster, I Hołowacz, G B Sunil Kumar, et al.Pageof 2